Organoid research breakthroughs in 2024: A review

Organoid research has experienced significant advancements in 2024, revolutionizing the fields of disease modeling, drug discovery, and regenerative medicine. Key innovations include the refinement of culture protocols for generating more physiologically relevant organoids derived from a wide range of human tissues, facilitated by improved differentiation protocols for induced pluripotent stem cells and adult stem cells. These advancements have led to organoids that better mimic in vivo tissue architecture and function, making them more suitable for studying complex diseases. The integration of microfluidics and biomaterial scaffolds into organoid cultures has further enhanced the replication of organ-specific microenvironments. In addition, the application of cutting-edge genomic tools, such as CRISPR/Cas9 gene editing, single-cell RNA sequencing, and high-throughput screening, has enabled the generation of organoid models with precise genetic mutations, facilitating the exploration of disease mechanisms and the screening of therapeutic agents. Artificial intelligence and machine learning have played a pivotal role in analyzing organoid data, enabling high-throughput screening and the development of personalized treatment strategies. While challenges remain in scalability, reproducibility, and vascularization, the innovations made in 2024 have set the stage for future clinical applications of organoid technologies, offering new possibilities for personalized medicine, drug development, and regenerative therapies.